Perspectives on the clinical use of anti-amyloid therapy for the treatment of Alzheimer's disease: Insights from the fields of cancer, rheumatology, and neurology.

Alzheimers Dement (N Y) · 2024 · PMC11409193 · PMID 39296920

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Such costs may be significant, and these additional expenses should be factored into the cost‐benefit analysis of anti‐amyloid therapy.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.